CN101533019A - New method for detecting plague antibodies in serum sample and product thereof - Google Patents

New method for detecting plague antibodies in serum sample and product thereof Download PDF

Info

Publication number
CN101533019A
CN101533019A CN200910082599A CN200910082599A CN101533019A CN 101533019 A CN101533019 A CN 101533019A CN 200910082599 A CN200910082599 A CN 200910082599A CN 200910082599 A CN200910082599 A CN 200910082599A CN 101533019 A CN101533019 A CN 101533019A
Authority
CN
China
Prior art keywords
detection
antibody
sample
pestis
microballoon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910082599A
Other languages
Chinese (zh)
Inventor
王静
杨永莉
孙肖红
杨宇
胡孔新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese Academy of Inspection and Quarantine CAIQ
Original Assignee
Chinese Academy of Inspection and Quarantine CAIQ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese Academy of Inspection and Quarantine CAIQ filed Critical Chinese Academy of Inspection and Quarantine CAIQ
Priority to CN200910082599A priority Critical patent/CN101533019A/en
Publication of CN101533019A publication Critical patent/CN101533019A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to a new method and for detecting plague antibodies in serum sample a product thereof. The method of the invention has good detection ability, high flexibility, strong specificity and wide dynamic range, and establishes open detection modelization platform detected by pathogenic bacterium antibody protein suspended chip using plague antibodies as representatives.

Description

The method and the product of plague antibodies in a kind of new detection serum sample
Technical field
The present invention relates to the quantitative detecting method of plague antibodies in a kind of new detection serum sample and product and preparation method thereof.
Background technology
Yersinia pestis (Yersinia pestis) belongs to yersinia's genus (Yersina), is the pathogen that causes the deadly infectious disease plague (Plague).The plague is the dangerous infectious disease of a kind of state of an illness, infectiousness is strong, fatal rate is 30% to 100%, approximately be 2 to 7 days the latent period of the plague, and various initial stage symptom is had a high fever, severe headache, vomiting, face's flush, furious, skin have the blutpunkte, clouding of consciousness, four limbs severe pain, regional glandular enlargement or the like.
Utilize antigen and antibody specificity to react in the immunological method enzyme linked immunological experiment (ELISA) to detect antigen or antibody to mainly contain and survey antibody, double-antibody sandwich survey antigen, competition law, indirect method etc. by double antigens sandwich.The principle that indirect method is surveyed antibody is that specific antigen is attached on the solid phase carrier, then with serum to be checked in corresponding antibodies in conjunction with forming immune complex, the antibodies that adds again after the washing in enzymic-labelled antibody and the immune complex forms enzymic-labelled antibody-antibody-solid phase antigen compound, add the substrate colour developing, judge antibody content.
Suspending chip (suspension array) also claim liquid-phase chip, it is the biochip technology of new generation that the seventies in 20th century, U.S. Luminex company developed, the microsphere that utilizes the band coding is as carrier, flow cytometer is measured biomolecule such as nucleic acid, protein on a large scale as detection platform.At present, this technology has been widely used in the fields such as discriminance analysis of immunoassay, nucleic acids research, enzymatic analysis, antibody screening and acceptor and part.
The suspending chip of development mainly is based on the detection of cell factor at present.But whether suspending chip can detect the plague antibodies in the human serum, still lacks model and evaluation.
Summary of the invention
The present invention relates to the protein suspension chip of plague antibodies in a kind of new detection serum, this chip comprises: coding microball, as wrapping by the pestis F 1 antigen of microballoon antigen, biotin labeled goat anti-rabbit igg and goat anti-human igg are as detecting antibody, streptavidin-phycoerythrin and suitable buffer solution.
The invention provides the preparation method of the protein suspension chip of above-mentioned detection plague antibodies, it is characterized in that, in relevant buffer solution, coding microball is antigen coated with pestis F 1, be that goat anti-rabbit igg, goat anti-human igg, usefulness streptavidin-phycoerythrin (SA-PE) are as signal detection with biotin labeled detection antibody.
The invention provides a kind of protein suspension chip quantitative detecting method of plague antibodies, this method adopts indirect method to detect the immunology detection principle of antibody, it is characterized in that, in testing process, respond and on 96 hole filter plates or in microcentrifugal tube, to carry out, comprising the following step: add to contain in (1) every hole or the pipe and wrap the antigen that is hunted down, be the working solution of the antigen coated coding microball of pestis F 1, clean with cleaning fluid; (2) add the test serum sample, hatch the back and clean; (3) add biotinylated detection antibody, hatch the back and clean; (4) add streptavidin-phycoerythrin (SA-PE), hatch the back and clean, mixing after (5) adding detection damping fluid, (6) read MFI numerical value (being average fluorescent strength) with suspension chip system and analyze the data judging testing result negative or positive.
The present invention also provides a kind of protein suspension chip quantitative detecting method that detects plague antibodies in the blood serum sample, it is characterized in that, this method comprises the following steps: that positive detection sample that (1) adds or standard items are through 4 times of gradient multiple proportions serial dilutions, (2) the dose-response typical curve of the corresponding MFI value of making sample concentration, (3) with analysis software match dose-response curve and equation, (4) can judge dynamic detection range according to dose-response curve, the unknown concentration sample can go out the concentration of test sample according to the dose-response Equation for Calculating, goes back the detectability of decidable method.
The ultimate principle of suspending chip is to utilize the microballoon of polystyrene (polystyrene) made, coat the ruddiness and the infrared light colour former of different proportion, and produce 100 kinds of different proportion colors, color numbers as 100 kinds of uniquenesses, every about 5.6 μ m of microballoon size, different research purposes such as immunoassay, nucleic acids research, enzyme analysis, acceptor and part discriminance analysis etc. be can comply with, and specific antibodies, nucleic acid probe and various acceptor probe demarcated according to different research purposes.The microballoon of label probe and determinand react in 96 orifice plates.After the reaction, utilize machine automatically reactant liquor to be picked up and by a microcapillary sense channel, only allow a microballoon to pass through sense channel at every turn.Being provided with twice laser in the sense channel, is red together, excites the color in the microballoon matrix, and the sorting code number of identification microballoon is to determine test item; Be green together, excite the color of reporter molecules, the tracer signal power is to detect the content of determinand.When the probe of sample to be tested and specific microballoon was attached together, the light that twice laser is excited all can be detected.And, then only have the exciting light in the microballoon to be detected if do not contain this subject matter in the sample.Microballoon kind and the quantity that is excited by machine and computing machine automatic statistical analysis twice laser again, thereby several test target things are arranged therein in the judgement sample to be tested, learn to have or not cause of disease to be measured to exist in the test sample book, or have several simultaneously to tens of kinds of cause of diseases.The suspending chip technology is owing to utilize microballoon to react in solution, overcome sheet film chip and when big Molecular Detection, be subjected to the influence to reaction kinetics such as surface tension, steric effect, utilize laser measuring technology simultaneously, improve the accuracy and the repeatability of sample detection greatly, had characteristics such as easy and simple to handle, the good reproducibility that is better than sheet film chip.
The inventor has done substantial improvement and innovation through a large amount of and deep research to the protein suspension chip preparation and the testing conditions thereof of plague antibodies, and it has following advantage:
1, the improvement of antigen coated amount
The package amount of pestis F 1 antigen is the key that successfully detects, the present invention is carried out substantive optimization to bag by the antigen coated amount of microballoon makes the detection effect of serum sample very good, and wrap very lowly by the required antigen coated amount of suspending chip, antigen coated amount of the present invention is 3-9 μ g/1.25 * 10 6Individual microballoon, i.e. 6-36ng/2500-5000 microballoon/test, and package amount is 5 μ g/ hole/tests in the general ELISA method.
2, biotin labeled improvement
Usually, labelled antibody need use excessive biotin.Theoretically, in testing process, excessive biotin is fallen by suction filtration during cleaning because of the unmarked antibody of going up is not connected by the antibody in conjunction with capture antibody on the microballoon, can not react with the SA-PE that adds subsequently, does not influence detection.But in the actual detected process, the phenomenon that the detection signal that fell in may be too high false positive occurs, so behind the application's biotin labeling antibody, removes unnecessary biotin as far as possible.IgG (molecular weight 150,000) 1mL solution with mark 2mg/mL is example, needs to add the about 27 μ L of 10mM biotin solution.
3, sensitivity of Jian Ceing and dynamic range
The quantitative detecting method of blood serum sample plague antibodies of the present invention is compared with the immunology ELISA detection method of classics with chip, and the result has good anastomose property (coefficient R 2=0.9994).Simultaneously, suspension chip method sensitivity is 2.12ng/mL, is higher than the 312.5ng/mL of ELISA method, and sensitivity is increased more than 100 times; And suspension chip method dynamic detection range of the present invention is 1.22~2000000ng/mL, is higher than ELISA method dynamic detection range 312.5~20000ng/mL and reaches 2 orders of magnitude.
4, the specificity of method
The present invention is an envelope antigen by selecting pestis F 1 antigen for use, is antibody to be measured with the anti-pestis F 1 antibody of rabbit, serves as to detect antibody with biotinylated goat anti-rabbit igg.This development test proves, exists mouse-anti influenza NPIgG, rabbit anti-avian influenza H5N1IgG, rabbit approach antibody, the anti-SARS IgG of rabbit to disturb under the antibody existence condition, and this method has good specificity.
5, the detectability of sample
The present invention has estimated the detectability of suspension chip method to human serum.By detection to human serum, tentative confirmation the practicality of this method plague antibodies in detecting human serum.
Description of drawings:
Fig. 1: No. 043 microballoon bag is by pestis F 1 Protein Detection plague antibodies synoptic diagram;
Fig. 2: the protein suspension chip method detects the dose-response canonical plotting of the anti-pestis F 1 antibody of rabbit;
Fig. 3: the ELISA method detects the anti-pestis F 1 antibody of rabbit canonical plotting;
Fig. 4: protein suspending chip and ELISA method detect the correlativity of the anti-pestis F 1 antibody of rabbit.
Embodiment
Protein suspension chip preparation method, detection and the quantivative approach of the detection plague antibodies that the present invention relates to are described further by following embodiment, but the present invention is subjected to the qualification of this embodiment never in any form.
One, material
1. the relevant damping fluid of protein suspension chip:
(1) PBS damping fluid (pH7.4): NaCl 137mmol/L; KCl 2.7mmol/L; Na 2HPO 410mmol/L; KH 2PO 42mmol/L.With 800mL dissolved in distilled water 8gNaCl, 0.2gKCl, 1.44gNa 2HPO 4With 0.24g KH 2PO 4PH value to 7.4 with the HCl regulator solution adds water to 1L.After the packing at 15psi (1.05kg/cm 2) high pressure steam 20 minutes, or filtration sterilization, be stored in room temperature.
(2) microballoon cleaning fluid: PBS (pH7.4), 0.05%TWEEN-20.
(3) microballoon activation damping fluid 100mM NaH 2PO 4: 3g NaH 2PO 4, 5N NaOH 1.5mL, constant volume be in 250mL, pH6.2.
(4) the microballoon bag is cushioned liquid 0.05M MES, pH5.0:2.44g MES, and 5N NaOH 0.15mL, constant volume is in 250mL.
(5) microballoon is preserved liquid PBS-TBN:PBS, 0.1%BSA, 0.02%TWEEN, 0.05% azide, pH7.4.
(6) microballoon confining liquid PBS-BN:PBS, 1%BSA, 0.05% azide, pH7.4.
(7) detect damping fluid: PBS, 1%BSA, pH7.4.
(8) antibody diluent PBS, pH7.4.
(9) microballoon dilution: PBS, 1%BSA, pH7.4.
(10) sample diluting liquid PVX:PBS, 0.5%PVA, 0.8%PVP;
(11) biotinylated antibody dilution: PBS-TBN (PBS, 0.1%BSA, 0.02%TWEEN-20,0.05%NaN3, pH7.4).
(12) SA-PE dilution: PBS (pH7.4), 1%BSA.
2. antigen and antibody
The present invention uses pestis F 1 antigen as detecting antigen.
Antibody to be measured used herein is the anti-pestis F 1 antigen of rabbit polyclonal antibody.
Detection antibody used herein is biotinylation goat anti-rabbit igg, biotinylation goat anti-human igg.
Two, the preparation of testing sample
1, the preparation of target analysis matter sample
Target analytes is the anti-pestis F 1 IgG of rabbit, disturbed specimen or the sample of testing as the method specificity are other antibody or other protein of target detection beyond the region of objective existence, comprise rabbit antitubercle serum, the anti-SARS IgG of rabbit, rabbit anti-avian influenza H5N1 serum, the anti-plague IgG of rabbit, BSA, casein, tryptone etc.Above-mentioned sample to be analyzed all is dissolved in the sample diluting liquid 4 ℃ of preservations.The storing solution concentration of rabbit anti-avian influenza H5N1 IgG is 0.2mg/mL.In the comparative experiments, same sample is used for the detection of ELISA and suspending chip.
Anti-pestis F 1 IgG is the variable concentrations sample with sample diluting liquid with 4 times of multiple proportions serial dilutions with rabbit to be analyzed, to draw the typical curve of sample detection dose-response, wherein several sample concentrations are lower than the susceptibility of detection, and enriched sample should make the binding site of coding microball be in state of saturation.
2, the processing of human serum sample
Respectively with plague patients serum sample and healthy human serum sample with diluted sample dilution in 1: 10, for example add sample dilution 50 μ L mixings as human serum sample 5 μ L after, carry out the detection of suspension chip method as sample to be checked.
The preparation of the protein suspension chip of embodiment 1, detection plague antibodies
1, the capture antigen bag microballoon that is encoded
No. 043 coding microball that the present invention adopts is available from U.S. BIO-RAD company, and coding microball is used for the pestis F 1 proteantigen that mark can be caught plague antibodies, promptly utilizes pestis F 1 albumen bag by microballoon.
The activation of A, coding microball
Coding microball is in the 1.5mL centrifuge tube to get 100 μ L (1.25 * 106), and 14000 * g is centrifugal, careful sucking-off and abandoning supernatant.The microballoon cleaning buffer solution that adds 100 μ L suspends, and concussion and ultrasonic back 14000 * g are centrifugal, careful sucking-off and abandoning supernatant.The microballoon that adds 100 μ L activates damping fluid, then adds the EDC (50mg/mL) of the fresh configuration of 10 μ L earlier, adds the Sulfo-NHS of the 50mg/mL of the fresh configuration of 10 μ L again, shakes after 30 seconds at a high speed and wraps up with aluminium foil, jolts 20 minutes in room temperature.Add the PBS (pH7.4) of 150 μ L, after the concussion, 14000 * g is centrifugal, careful sucking-off and abandoning supernatant.PBS (pH7.4) the suspended coding microballoon that adds 100 μ L.
B, use antigen coated coding microball
Get in the coding microball after capture antigen pestis F 1 proteantigen 4-50 μ g joins activation, be settled to 500 μ L with the PBS damping fluid, room temperature jolts 2 hours.14000 * g is centrifugal, careful sucking-off and abandoning supernatant.PBS damping fluid with 500 μ L is washed once, and 14000 * g is centrifugal, careful sucking-off and abandoning supernatant.Add the sealing damping fluid suspended coding microballoon of 250 μ L, jolt 30 minutes in room temperature, 14000 * g is centrifugal, careful sucking-off and abandoning supernatant.The microballoon that adds 500 μ L is preserved liquid washing coding microball, and 16000 * g is centrifugal, careful sucking-off and abandoning supernatant.Preserve liquid suspended coding microballoon with the microballoon of 150 μ L at last, keep in Dark Place standby in 4 ℃.
C, bag are by the counting of microballoon
Draw an amount of microballoon, after the dilution, with blood counting chamber (0.10mm; 1/400mm 2) under simple microscope, count.According to formula (each big lattice number * 10 4* extension rate * volume (mL)) calculates microballoon quantity.
2, detect the antibody labeling biotin
The mark of A, biotin
Preparing concentration respectively is the antibody-solutions to be marked of 10mM biotin solution and 2mg/mL, and the biotin that has calculated volume is joined in the antibody-solutions to be marked, jolts 30 minutes in room temperature (or 2 hours) on ice, packing after the post desalination excessively, and-20 ℃ are frozen standby.
The consumption of B, antibody
IgG (molecular weight 150,000) 1mL solution with mark 2mg/mL is example, needs to add the about 27 μ L of 10mM biotin solution.
The optimization of embodiment 2, suspending chip preparation method condition
1, the selection of microballoon envelope antigen package amount
Amount bag with 1 μ g, 3 μ g, 6 μ g, 9 μ g, 12 μ g, 15 μ g, 20 μ g is encoded to No. 027 microballoon by 100 μ L respectively.Effect compares after testing, with 6 μ g/1.25 * 10 6Individual microballoon is that 12-24ng/2500-5000 microballoon/test pack is best by effect, and microscopically counting back lucifuge stored refrigerated is stand-by.
As shown in Figure 1, bag is all dropped in its correct surveyed area by No. 043 microballoon of pestis F 1 proteantigen, and obtains high s/n ratio result (the MFI value is much larger than 2000), illustrates that the suspending chip detection system of optimizing can successfully be used for the detection of plague antibodies.
2, the optimization of biotinylated antibody
The present invention uses amino active biotin respectively, the biotin of LC-hydrazides (hydrazide)-biotin and carboxyl activity for example, for example the biotin labeling of Sulfo-NHS-biotin and SH-activity detects antibody, detect effect relatively through the Quality Control process, it is better that the biotin labeling of SH-activity detects the antibody test effect in this experiment, and the method that detects effect adopts the conventional method of this area or the described method of product description of installation manufacturer.
The inventor is through verification experimental verification, as detecting plague antibodies in the rabbit anteserum, testing result showed that biotinylation detects the detection effect that antibody Bio-goat anti-rabbit antibody can obtain the Supreme People's Procuratorate's measured value and low background to the biotinylated antibody goat-anti of discovery 2mg/mL rabbit with dilution in 1: 250; As detecting plague antibodies in the human serum, testing result showed that biotinylation detects the detection effect that antibody Bio-goat anti-human antibody can obtain the Supreme People's Procuratorate's measured value and low background to the biotinylated antibody goat-anti of 2mg/mL people with dilution in 1: 2500.
Embodiment 3, suspending chip specimen preparation, detection and result judge
1, testing sample preparation
With sample diluting liquid sample to be tested is configured to the variable concentrations sample and carries out the protein suspension chip detection.
2, the detection of sample and result judge
The testing process total overall reaction is all carried out on 96 hole filter plates, and testing process is as follows:
1) every hole adds the working solution that 50 μ L contain the corresponding encoded microballoon, washs and use the vacuum pump suction filtration with cleaning fluid;
2) add 50 μ L test sample, the room temperature lucifuge jolts 30 minutes behind the mixing, with cleaning fluid washing and suction filtration;
3) add 50 μ L debita spissitudos with the biotinylated antibody after the antibody diluent dilution, the room temperature lucifuge jolts 30 minutes behind the mixing, washing lotion washing and vacuum pump suction filtration;
4) SA-PE of adding 50 μ L, the room temperature lucifuge jolts 10 minutes behind the mixing.Washing lotion washing and vacuum pump suction filtration;
5) the detection damping fluid of adding 125 μ L is through the resuspended mixing of spiral;
6) read MFI numerical value and analyze data with suspension chip system.
3, testing result is judged
According to experimental study result and correlative study report, the present invention defines the protein suspension chip method and detects the detection substrate concentration of the minimum detectability (LOD value) of plague antibodies for fluorescence intensity critical value (Cutoff) correspondence.Wherein, the definition of Cutoff is to adopt blank sample (Blank) fluoroscopic examination signal MFI average to add 3 times of standard deviations (SD), and promptly the Cutoff value is=MFI (blank)+3 times standard deviation.Corresponding fluorescence intensity level then is judged to be the plague antibodies testing result positive if testing result is higher than Cutoff; Corresponding fluorescence intensity level then is judged to be plague antibodies testing result feminine gender if testing result is lower than Cutoff.
Embodiment 4, suspending chip are to pestis F 1 proteantigen specific detection
The using suspending chip detection method detects rabbit approach IgG, mouse-anti influenza NP IgG, the anti-SARSIgG of rabbit, rabbit anti-avian influenza H5N1 serum, the anti-pestis F 1 IgG of rabbit, BSA, casein, tryptone etc. respectively, according to testing result criterion among the embodiment 3, only the anti-pestis F 1 IgG of rabbit is positive, and all the other interference antibody or albumen are all negative.Cross reaction or non-specific responding all do not take place in protein suspension chip detection method and other test antibody that the plague antibodies that the present invention sets up is described.
The foundation of embodiment 5, suspending chip detection by quantitative model
1, the anti-pestis F 1 IgG of rabbit typical curve specimen preparation
With sample diluting liquid the anti-pestis F 1 IgG of rabbit standard items are become series concentration sample with 4 times of multiple proportions gradient dilutions to 73.6pg/mL by 80 μ g/mL.
2, the drafting of dose-response typical curve
Detect above-mentioned series concentration sample according to the detection method among the embodiment 3, and draw dose-response typical curve (as shown in Figure 2) according to the suspension chip system testing result.Wherein, X-axis is represented the concentration (ng/mL) of antibody, the fluorescent value (MFI) that on behalf of the suspending chip instrument, Y-axis detect.The testing result mean value that each is data represented 3 times, coordinate axis is set with logarithm-logarithmic relationship, and the concentration (ng/mL) of the anti-pestis F 1 IgG of rabbit is respectively among Fig. 2: S1:0.0763, S2:0.305, S3:1.221, S4:4.883, S5:19.531, S6:78.125, S7:312.5, S8:1250.0, S9:5000.0, S10:20000.0.
Suspension chip system is according to the anti-pestis F 1 IgG of testing result match rabbit dose-response typical curve equation: FI=-7.99831+ (16838.6+7.99831)/[1+ (Conc/1006.33) -3.53611] 0.198701
3, suspending chip detects sensitivity and the dynamic range of the anti-pestis F 1 IgG of rabbit
According to minimum detectability definition and dose-response typical curve equation, the present invention is that the sensitivity of the anti-pestis F 1 IgG of protein suspension chip method detection rabbit is: and 50.3pg/mL (Cutoff=8, Blank=8, SD=0).
It is to make the binding site of coding microball be in the detection substrate concentration of state of saturation that the present invention defines Supreme Procuratorate's rising limit.According to the rising of typical curve along with the anti-pestis F 1 IgG of rabbit concentration, its corresponding MFI value also increases progressively thereupon, when the anti-pestis F 1 IgG of rabbit concentration reaches 0.025mg/mL, the immune response of the antigen-antibody state that promptly reaches capacity, the MFI value also enters plateau, substrate concentration height to be checked in the interpret sample need will detect after the enriched sample dilution again.
Therefore, can judge that according to minimum detectability and Supreme Procuratorate's rising limit the present invention is that the dynamic range of the anti-pestis F 1 IgG of suspending chip detection by quantitative rabbit is 4.883~25000ng/mL.
Embodiment 6, protein suspension chip method and ELISA method detect the comparison of the anti-pestis F 1 antibody of rabbit
1, biotin-avidin ELISA (BAS-ELISA) detection method
As a comparison, biotin-avidin ELISA adopts and comprises the following steps:
1) adds the bird flu H5 albumen 5-50 μ g of 50 μ L with the dilution of PBS damping fluid, 4 ℃ of static spending the night to the every hole of common ELISA microwell plate;
2) add confining liquid, 37 ℃ of sealings 2 hours;
3) washing lotion is washed 3 times, pats dry;
4) add test sample, every hole 50 μ L, room temperature was placed 40 minutes; Washing lotion is washed 3 times, pats dry;
5) add an amount of biotinylation and detect antibody, every hole 50 μ L, room temperature was placed 30 minutes; Washing lotion is washed 3 times, pats dry;
6) add an amount of SA/HRP (horseradish enzyme labeling Streptavidin), 50 μ L/ holes, room temperature was placed 3 minutes; Washing lotion is washed 3 times, pats dry;
7) add TMB colour developing liquid (solvable type single component tmb substrate solution) colour developing, 50 μ L/ holes, room temperature was placed 10 minutes;
8) use 2M H 2SO 4Cessation reaction;
9) use the microplate reader survey and read A450nm numerical value.
2, method for detecting suspension chip of the present invention
Adopt indirect method to survey the immunology detection pattern of antibody, total overall reaction is all carried out on 96 hole filter plates in the testing process.
1) every hole adds the working solution that 50 μ L contain the corresponding encoded microballoon, washing lotion washing and with vacuum pump suction filtration 2 times;
2) add 50 μ L test sample, the room temperature lucifuge jolts 30 minutes behind the mixing, with cleaning fluid washing and suction filtration 3 times;
3) add 50 μ L debita spissitudos with the biotinylated antibody after the antibody diluent dilution, the room temperature lucifuge jolts 30 minutes behind the mixing, washing lotion washing and vacuum pump suction filtration 3 times;
4) SA-PE of adding 50 μ L, the room temperature lucifuge jolts 10 minutes behind the mixing.With cleaning fluid washing and vacuum pump suction filtration 3 times;
5) the detection damping fluid of adding 125 μ L is through the resuspended mixing of spiral;
6) read MFI numerical value and analyze data with the Bio-Plex suspension chip system.
3, the comparison of the sensitivity of two kinds of detection methods and dynamic range and correlativity
The anti-pestis F 1 antibody of the mutually same group rabbit sample of preparation detects with sample diluting liquid 4 doubling dilutions while using suspending chip and ELISA method.Draw the typical curve (horizontal ordinate is a sample concentration among the figure, and ordinate is an absorbance, and coordinate axis is taken the logarithm-logarithmic relationship) that the ELISA method detects the anti-pestis F 1 antibody of rabbit, and compare with the suspension chip method result.
According to two kinds of method standard curves: suspension chip method sensitivity as shown in Figure 2 is 2.12ng/mL, linear detection range 1.22~2000000ng/mL; The sensitivity as shown in Figure 3 of ELISA method is 312.5/mL, linear detection range 312.5~20000ng/mL.Can reach a conclusion: detect the anti-pestis F 1 antibody of identical rabbit sample, the protein suspension chip method has higher detection sensitivity than ELISA method, and is promptly high 100 times; And has wideer dynamic detection range, promptly high 2 orders of magnitude.
In addition, as shown in Figure 4, two kinds of method testing results are compared in 312.5~20000ng/mL scope can judge that protein suspension chip method and ELISA method have good correlativity, related coefficient is 0.9994.
Embodiment 7, human serum sample's detection
1, human serum sample's preparation
The human serum sample is used for protein suspension chip after with sample diluting liquid 1: 10 dilution (human serum sample 5 μ L add sample dilution 50 μ L mixings) to be detected.
2, human serum sample's detection
1) every hole adds the working solution that 50 μ L contain the corresponding encoded microballoon, washs and use the vacuum pump suction filtration with cleaning fluid;
2) add 50 μ L human serum sample to be detected, the room temperature lucifuge jolts 30 minutes behind the mixing, with cleaning fluid washing and suction filtration;
3) add 50 μ L debita spissitudos with the biotinylation goat anti-human antibody after the antibody diluent dilution, the room temperature lucifuge jolts 30 minutes behind the mixing, washing lotion washing and vacuum pump suction filtration;
4) SA-PE of adding 50 μ L, the room temperature lucifuge jolts 10 minutes behind the mixing.Washing lotion washing and vacuum pump suction filtration;
5) the detection damping fluid of adding 125 μ L is through the resuspended mixing of spiral;
6) read MFI numerical value with suspension chip system,, determine the concentration of plague antibodies in the human serum to be detected according to typical curve.
Through revision test repeatedly, biotinylation goat anti-human igg dilution ratio is selected the 1:2500 dilution for use, the SA-PE dilution ratio is selected the 1:300 dilution for use, through detection to 94 parts of human serums, 3 times of sums of the average of the MFI value of gained and its standard deviation are as the dividing value of judging yin and yang attribute, be that C utoff value is 632.35, being scaled concentration value is 9.6ng/mL, if the MFI value that detection obtains is greater than 632.35, be that plague antibodies concentration in the serum surpasses 9.6ng/mL and can be considered the plague antibodies positive and may be infected by the plague, if the MFI value is less than 632.35, promptly the plague antibodies concentration in the serum is lower than 9.6ng/mL and can be judged as the plague antibodies feminine gender, does not infect the plague.

Claims (9)

1, a kind of indirect immunology quantitative detecting method that adopts protein suspension chip to detect plague antibodies in the blood serum sample is characterized in that total overall reaction can be carried out in the testing process in 96 hole filter plates or microcentrifugal tube, and this method comprises the following steps:
(1) bag is the pestis F 1 proteantigen by the capture antigen of microballoon;
(2) adding contains the working solution that wraps the antigen encoding microballoon that is hunted down in the hole, cleans with cleaning fluid;
(3) add the test serum sample, hatch the back and clean;
(4) add with biotinylated detection antibody, hatch the back and clean;
(5) add streptavidin-phycoerythrin, hatch the back and clean;
(6) mixing after the adding detection damping fluid;
(7) read average fluorescent strength (MFI) numerical value and analyze the data judging testing result with suspension chip system.
2, the method for claim 1 is characterized in that, adopts biotin labeled goat anti-human igg as detecting antibody, itself and the combination composition indirect method detection architecture of pestis F 1 proteantigen.
3, the method for claim 1 is characterized in that, described bag is 6 μ g/1.25 * 10 by the capture antigen pestis F 1 proteantigen consumption of microballoon 6Individual coding microball or 12~24ng/2500-5000 microballoon/test.
4, the method for claim 1 is characterized in that, the biotin of the marker detection antibody goat anti-human igg in the described method is the biotin of carboxyl activity.
5, the method for claim 1 is characterized in that, the biotinylated detection antibody of 2mg/mL Bio-goat anti-human igg detects as detecting antibody with the 1:2500 dilution.
6, the protein suspension chip method of plague antibodies in a kind of detection by quantitative blood serum sample is characterized in that this method comprises the following steps:
(1) positive detection sample of Jia Ruing or standard items are through the gradient doubling dilution, and described gradient doubling dilution is 4 times;
(2) series of diluted samples is detected in suspension chip system read corresponding fluorescent value (MFI);
(3) dose-response curve of the corresponding MFI value of making sample concentration;
(4) with analysis software match dose-response curve and equation;
(5) the unknown concentration sample can is characterized in that the positive detection sample that adds is the anti-pestis F 1 IgG of rabbit according to the concentration of plague antibodies in dose-response curve and the equation judgement unknown sample.
7, method as claimed in claim 6 is characterized in that, being used to wrap by the capture antigen of microballoon is pestis F 1 albumen, adopt biotin labeled goat anti-rabbit antibody as detection antibody, and indirect method detection architecture is formed in its combination.
8, a kind of protein suspension chip that detects plague antibodies in the blood serum sample, this chip comprises: coding microball, by the pestis F 1 antigen of microballoon antigen, biotin labeled goat anti-rabbit igg and goat anti-human igg are as detecting antibody, streptavidin-phycoerythrin and suitable buffer solution as bag.
9, the preparation method of the described protein suspension chip of claim 8, it is characterized in that, in relevant buffer solution, coding microball is antigen coated with pestis F 1, be that goat anti-rabbit igg and goat anti-human igg, usefulness streptavidin-phycoerythrin (SA-PE) are as signal detection with biotin labeled detection antibody.
CN200910082599A 2009-04-28 2009-04-28 New method for detecting plague antibodies in serum sample and product thereof Pending CN101533019A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910082599A CN101533019A (en) 2009-04-28 2009-04-28 New method for detecting plague antibodies in serum sample and product thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910082599A CN101533019A (en) 2009-04-28 2009-04-28 New method for detecting plague antibodies in serum sample and product thereof

Publications (1)

Publication Number Publication Date
CN101533019A true CN101533019A (en) 2009-09-16

Family

ID=41103747

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910082599A Pending CN101533019A (en) 2009-04-28 2009-04-28 New method for detecting plague antibodies in serum sample and product thereof

Country Status (1)

Country Link
CN (1) CN101533019A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101936990A (en) * 2010-07-23 2011-01-05 中国检验检疫科学研究院 Preparation method and using method of protein suspension chip for detecting tick borne encephalitis antibody in serum sample
CN107192823A (en) * 2017-06-08 2017-09-22 杭州遂真生物技术有限公司 A kind of B races streptozyme linked immune assay kit

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101936990A (en) * 2010-07-23 2011-01-05 中国检验检疫科学研究院 Preparation method and using method of protein suspension chip for detecting tick borne encephalitis antibody in serum sample
CN107192823A (en) * 2017-06-08 2017-09-22 杭州遂真生物技术有限公司 A kind of B races streptozyme linked immune assay kit
CN107192823B (en) * 2017-06-08 2024-03-19 杭州遂真生物技术有限公司 Group B streptococcus enzyme-linked immunosorbent assay kit

Similar Documents

Publication Publication Date Title
CN103698535B (en) Platelet-activating factor acetylhydro-lase immue quantitative detection reagent box and preparation, method of operating
JP4274944B2 (en) Particle-based ligand assay with extended dynamic range
CN101377514A (en) Insulin autoantibody chemiluminescence immune analysis determination reagent kit and preparing method thereof
CN101504414A (en) Important heating pathogen fast screening system
CN101533021A (en) New method and product for detecting tuberculosis antibody in serum sample
CN101533020A (en) New method for detecting SARS antibody in serum sample and a product thereof
Lee et al. Rapid immunofiltration assay of Newcastle disease virus using a silicon sensor
CN101533019A (en) New method for detecting plague antibodies in serum sample and product thereof
CN101963616B (en) Protein suspension array for detecting tularaemia antibody in serum sample, preparation method and using method thereof
EP0201211A1 (en) Method and compositions for visual solid phase immunoassays based on luminescent microspheric particles
CN101498720A (en) Protein suspending chip for quantitative detection of staphylococcal enterotoxin B and method for producing the same
CN101545905A (en) Methods for preparing, quantifying and detecting protein suspension chip of ricin
CN203133084U (en) Protein suspension array system for detecting tick-borne encephalitis antibody in serum sample
CN202024995U (en) Protein suspension array system for detecting Q hot rickettsia antibodies
CN202024997U (en) Protein suspension array system for detecting MaQiuBo antibodies
CN102183666A (en) Liquid phase chip for detecting twelve pathogen antibodies in blood serum sample in high flux, and preparation method and using method thereof
CN202024999U (en) Albumen suspension chip system for detecting Eastern equine encephalitis antibody
CN201903543U (en) Protein suspension array system for detecting avian influenza antibody in blood serums
CN203133085U (en) Protein suspension array system for detecting tularaemia antibody in serums
CN101533023A (en) New method and product for detecting avian influenza antibody in serum sample
CN201917573U (en) Protein suspension chip system for detecting plague antibodies in serum sample
CN112014382A (en) Chemiluminescence kit for detecting myoglobin content and application thereof
CN101915836A (en) Protein suspension chip for detecting dengue antibody in serum sample and preparation method and using method thereof
CN203133082U (en) Protein suspension array system for detecting various antibodies in serum sample synchronously
CN203133081U (en) Protein suspension array system for detecting dengue fever antibody in serum sample

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20090916